toripalimab
Showing 1 - 25 of 139
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
- toripalimab
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)
Not yet recruiting
- Advanced Urothelial Carcinoma
- 9MW2821
- Toripalimab
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Oct 9, 2023
Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)
Recruiting
- Advanced Solid Tumor
- RC118
- Toripalimab
-
Shanghai, Chinahongshan Hospital Affiliated to Fudan University
Sep 14, 2023
Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)
Recruiting
- Nasopharyngeal Carcinoma
- Toripalimab
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Apr 2, 2023
Solid Tumor Trial in Changchun (WX390, Toripalimab)
Recruiting
- Solid Tumor
- WX390
- Toripalimab
-
Changchun, Jilin, Chinathe first affiliated hospital of Jilin university
Nov 3, 2023
Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)
Recruiting
- Cervical Cancer
- +2 more
- Toripalimab
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Oct 16, 2023
NSCLC Trial in Shanghai (Toripalimab, Cryoablation)
Not yet recruiting
- Non-small Cell Lung Cancer
- Toripalimab
- Cryoablation
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 7, 2023
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)
Recruiting
- Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
- WX390
- Toripalimab
-
Shanghai, Shanghai, ChinaThe Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023
Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)
Recruiting
- Microsatellite Stable Metastatic Colorectal Cancer
- Regorafenib
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 19, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)
Not yet recruiting
- Head and Neck Cancer
- +9 more
- ILB-2109
- Toripalimab
- (no location specified)
Jul 12, 2023
Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)
Not yet recruiting
- Gastric Cancer
- RC48-ADC
- +4 more
-
Beijing, ChinaBeijing Cancer Hospital
Aug 7, 2023
NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)
Recruiting
- NSCLC
- SBRT+LDRT
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 2, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Toripalimab
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)
Not yet recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Capecitabine
- +3 more
-
Beijing, Beijing, China
- +10 more
Nov 23, 2023
Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)
Not yet recruiting
- Local Advanced Non-small Cell Lung Cancer
- Toripalimab
- Radical thoracic radiotherapy
- (no location specified)
Jun 2, 2023
Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)
Recruiting
- Lung Cancer
- Toripalimab
-
Jinan, Shandong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Dec 7, 2022
Rectal Cancer Trial in Chengdu (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Fruquintinib
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 8, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Toripalimab
- (no location specified)
Mar 20, 2023
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Toripalimab
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Endostar
- Toripalimab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)
Recruiting
- Esophageal Squamous Cell Cancer
- Toripalimab
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023
Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)
Not yet recruiting
- Gestational Trophoblastic Neoplasia
- Toripalimab
- Actinomycin-D
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 1, 2023
Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)
Not yet recruiting
- Gestational Trophoblastic Neoplasia
- Toripalimab
- Actinomycin-D
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 7, 2023